Posts by: Diana Campelo Delgado

Diana Campelo Delgado

Diana holds a PhD in Biomedical Sciences, with specialization in genetics, from Universidade Nova de Lisboa, Portugal. Her work has been focused on enzyme function, human genetics and drug metabolism.

February 1, 2021February 1, 2021

Magrolimab Achieves Positive Results in Ongoing Phase 1b Trial

News

Gilead Sciences’ investigational therapy magrolimab was well-tolerated and effective in untreated acute myeloid leukemia (AML) patients ineligible for intensive chemotherapy, according to data from a Phase 1b trial. These results ... Read more

January 28, 2021January 28, 2021

FDA Clears Way for Clinical Trial of VOR33 Stem Cell Therapy

News

Vor Biopharma has been cleared in the U.S. to begin clinical trial testing of its investigational cell therapy, VOR33, for acute myeloid leukemia (AML). The U.S. Food and Drug Administration ... Read more